Burns Matteson Capital Management’s Gilead Sciences GILD Stock Holding History

Burns Matteson Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,705	Closed	-$577K	–	152
2023 Q3	$577K	Buy	+7,705	New	+$593K	0.37%	72
2023 Q1	–	Sell	-9,044	Closed	-$776K	–	161
2022 Q4	$776K	Buy	+9,044	New	+$716K	0.51%	41
2022 Q3	–	Sell	-12,576	Closed	-$777K	–	135
2022 Q2	$777K	Buy	+12,576	New	+$779K	0.55%	39
2022 Q1	–	Sell	-8,713	Closed	-$633K	–	137
2021 Q4	$633K	Buy	+8,713	New	+$600K	0.43%	74

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Burns Matteson Capital Management's GILD Position: Q4 2023 in Review

Burns Matteson Capital Management sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 7,705 shares — an estimated $577K sold.

Burns Matteson Capital Management first reported a position in GILD in Q4 2021 and held it in 4 quarters. The position peaked at $777K in Q2 2022. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

Burns Matteson Capital Management reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
Burns Matteson Capital Management sold 7,705 Gilead Sciences shares in Q4 2023, an estimated $577K.
Burns Matteson Capital Management first reported a position in Gilead Sciences in Q4 2021 and held it in 4 quarters.
Burns Matteson Capital Management's Gilead Sciences position peaked at $777K in Q2 2022.
1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Burns Matteson Capital Management's 13F filing for Q4 2023, filed 12 Jan 2024.